Gartner Research

Supply Chain Brief: Life Science Supply Chains Are Underestimating the Threat of Changing Healthcare Payment Models

Published: 27 September 2016

ID: G00316760

Analyst(s): Stephen Meyer , Eric O'Daffer

Summary

Despite the well-publicized transition of payment models in healthcare, life science manufacturers don't consider it a top threat. That's the wrong conclusion. Life science supply chain leaders must understand how the transition to outcome-based payments will impact them and their customers.

Table Of Contents

What You Need to Know

Analysis

  • Background

Gartner Recommended Reading

©2020 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.